BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
Science Daily: Pharmacology News
FEBRUARY 24, 2025
Using a four-dimensional microscopy technique, researchers have created 3D video images of mouse lung tissue grown in the laboratory. What they have learned has been nothing short of groundbreaking.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says.Patients on semaglutide (Ozempic, Wegovy) had a.
Science Daily: Pharmacology News
FEBRUARY 24, 2025
Remember when 2 degrees Celsius of global warming was the doomsday scenario? Well, we're now staring down the barrel of something much worse. From the fish on your plate to the weather outside your window, everything's about to change. A new study underscores the grave risks posed by insufficient national commitments to reducing greenhouse gas emissions.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- Lea County, New Mexico, is now reporting an outbreak of measles, according to the New Mexico Department of Health (NMDOH). Lea County is near Gaines County, Texas, where measles cases continue to rise as part of the.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
Early-phase clinical trials, including phase 1 and some phase 2a studies, serve as a pivotal step for biotech companies, laying the foundation for a drug candidate’s journey to market.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- For the first time, bird flu has been detected in rats, the U.S. Department of Agriculture (USDA) confirmed, according to a recent report.Bird flu, otherwise known as H5N1 avian influenza, was found in four black rats in.
BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- With measles cases on the rise and flu season straining the nation's hospitals, health experts urge adults to check their vaccination status and get any missing shots.Health experts agree that vaccines are the best defense.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
FEBRUARY 24, 2025
New analysis of ancient fossilized rocks known as stromatolites, preserved in southern Zimbabwe, suggests strong links to hydrothermal nutrient recycling, 'meaning that early life may in part have been fueled by volcanic activity'.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- Narcissists may seem self-assured, but new research shows they often feel excluded -- and their behavior may be making things worse.Hallmarks of narcissm include an inflated sense of one's importance, a hunger for.
BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially landscape-changing combinations.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- A babys seizure in a neonatal ICU could be a red flag for future risk of epilepsy.Newborns who suffer seizures following birth are more likely to develop epilepsy in childhood and young adulthood, a new study suggests.More.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 (HealthDay news) -- Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearing out, a new study suggests.People with new knees and hips are significantly less likely.
BioPharma Drive: Drug Pricing
FEBRUARY 24, 2025
Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with Travere Therapeutics.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- A parents mental health appears to influence their kids chances of developing anxiety, ADHD and other behavioral disorders, a new study says.Children were more than four times as likely to develop severe ADHD (at.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Fierce BioTech
FEBRUARY 24, 2025
Transforming Early Detection in Oncology and Rare Diseases Using AI pesurya Mon, 02/24/2025 - 09:53 Wed, 04/09/2025 - 11:00 Resource Type Webinar Chris Tackaberry Dr. Will Ricketts Health systems around the globe face a difficult paradox: delivering more care with fewer resources. This challenge is critical across various medical fields including oncology and rare diseases where advances in early detection can increase life expectancy and decrease the cost of care.
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- Many patients with incurable cancer arent getting care that could ease their suffering at the end of life, a new study suggests.Close to half of patients with advanced cancer received aggressive cancer treatment within six.
Broad Institute
FEBRUARY 24, 2025
Broad-MIT Seminars in Chemical Biology: Phil Holliger By Rose Circeo February 24, 2025 Breadcrumb Home Broad-MIT Seminars in Chemical Biology: Phil Holliger Broad-MIT Seminars in Chemical Biology February 24, 2025 Broad Institute of MIT and Harvard Speaker: Phil Holliger, MRC Laboratory of Molecular Biology Talk title: Replicating RNA with RNA Description: A critical event in the origin of life is thought to have been the emergence of an RNA molecule capable of self-replication as well as mutati
Drugs.com
FEBRUARY 24, 2025
MONDAY, Feb. 24, 2025 -- Frequent exercise can help colon cancer survivors live longer, perhaps even outlasting average folks, a new study suggests.Colon cancer patients who were very physically active had three-year survival rates that were.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Crucial Data Solutions
FEBRUARY 24, 2025
The Impact of Bias on Clinical Trials and Patient Safety Bias, despite best efforts and best intentions, continues to impact. The post How EDC Software Minimizes Bias in Clinical Trials appeared first on Crucial Data Solutions.
Science Daily: Pharmacology News
FEBRUARY 24, 2025
A multidisciplinary and international research project has brought fresh insights into the origins and diversity of the populations that lived under and after the Hun empire between the late 4th and 6th century CE in Central Europe. Combining forefront archaeogenomic analyses with archaeological and historical investigation, the study connects some of the European Hun-period individuals directly to some high-status elite of the earlier Xiongnu Empire -- a powerful nomadic empire centered in the
Chemical Biology and Drug Design
FEBRUARY 24, 2025
Administration of STA inhibits intestine tissue destruction and inflammation in T2D mice and improves intestinal permeability in T2D mice, which is associated with the transition of GI microbiota to a novel homeostasis. ABSTRACT Stachydrine (STA) has therapeutic effects on heart disorders. The current study assessed its effects on Type 2 diabetes (T2D) induced cardiac disorders by focusing on the heartgut axis.
keypoint
FEBRUARY 24, 2025
Our February Fellow's Spotlight goes to Dr. Oleta Johnson! Dr. Johnsons is a William R. and Daniel L. Young Career Development Assistant Professor at MIT, where she uses chemical and biophysical tools to dissect the relationship between protein dynamics and function. Specifically, the Johnson Lab uses chemistry and biophysics to understand and tune molecular chaperone protein DnaJB6 and its ability to suppress the toxic accumulation of proteins associated with neurodegenerative diseases like Hun
Chemical Biology and Drug Design
FEBRUARY 24, 2025
Our study highlights the potential of RUT as an anti-cancer drug for NSCLC. Its ability to inhibit the growth of NSCLC cell lines with different mutations through G2/M arrest and apoptosis induction is promising. Moreover, the upregulation of the STING pathway and increased production of CXCL10 and CCL5 further support its potential as a therapeutic agent.
Expert insights. Personalized for you.
363 
Let's personalize your content